Relief Therapeutics Holding SA (RLFTF)
OTCMKTS · Delayed Price · Currency is USD
2.990
-0.030 (-0.99%)
Apr 25, 2025, 9:59 AM EDT

RLFTF Statistics

Total Valuation

RLFTF has a market cap or net worth of 35.67 million. The enterprise value is 20.05 million.

Market Cap 35.67M
Enterprise Value 20.05M

Important Dates

The last earnings date was Tuesday, April 1, 2025.

Earnings Date Apr 1, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +6.71%
Shares Change (QoQ) +12.10%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 9.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.84
PB Ratio 0.88
P/TBV Ratio 5.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.06
EV / Sales 1.97
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -6.20

Financial Position

The company has a current ratio of 3.95, with a Debt / Equity ratio of 0.06.

Current Ratio 3.95
Quick Ratio 3.43
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF -0.73
Interest Coverage -190.48

Financial Efficiency

Return on equity (ROE) is -38.52% and return on invested capital (ROIC) is -9.99%.

Return on Equity (ROE) -38.52%
Return on Assets (ROA) -7.35%
Return on Invested Capital (ROIC) -9.99%
Return on Capital Employed (ROCE) -15.79%
Revenue Per Employee 299,627
Profits Per Employee -609,400
Employee Count 31
Asset Turnover 0.13
Inventory Turnover 3.22

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +96.10% in the last 52 weeks. The beta is 4.45, so RLFTF's price volatility has been higher than the market average.

Beta (5Y) 4.45
52-Week Price Change +96.10%
50-Day Moving Average 3.07
200-Day Moving Average 3.63
Relative Strength Index (RSI) 47.54
Average Volume (20 Days) 1,958

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RLFTF had revenue of 9.29 million and -18.89 million in losses. Loss per share was -1.51.

Revenue 9.29M
Gross Profit 6.45M
Operating Income -8.41M
Pretax Income -21.36M
Net Income -18.89M
EBITDA -6.16M
EBIT -8.41M
Loss Per Share -1.51
Full Income Statement

Balance Sheet

The company has 16.64 million in cash and 2.36 million in debt, giving a net cash position of 14.28 million.

Cash & Cash Equivalents 16.64M
Total Debt 2.36M
Net Cash 14.28M
Net Cash Per Share n/a
Equity (Book Value) 40.46M
Book Value Per Share 3.23
Working Capital 16.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.22 million and capital expenditures -15,449, giving a free cash flow of -3.23 million.

Operating Cash Flow -3.22M
Capital Expenditures -15,449
Free Cash Flow -3.23M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 69.41%, with operating and profit margins of -90.52% and -203.39%.

Gross Margin 69.41%
Operating Margin -90.52%
Pretax Margin -229.96%
Profit Margin -203.39%
EBITDA Margin -66.27%
EBIT Margin -90.52%
FCF Margin n/a

Dividends & Yields

RLFTF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.71%
Shareholder Yield -6.71%
Earnings Yield -52.95%
FCF Yield -9.06%

Stock Splits

The last stock split was on May 5, 2023. It was a reverse split with a ratio of 0.0025.

Last Split Date May 5, 2023
Split Type Reverse
Split Ratio 0.0025

Scores

RLFTF has an Altman Z-Score of -5.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.14
Piotroski F-Score n/a